MTOR [45–52] is a target associated with breast cancer, bladder cancer, hysteromyoma, laryngeal cancer, kidney cancer, liver cancer, thyroid cancer, epidermoid squamous cell carcinoma, and colorectal cancer. Here, MTOR is linked to breast cancer.